ATE542523T1 - Pharmazeutische tabletten mit zwei oder mehr einheitlichen segmenten - Google Patents

Pharmazeutische tabletten mit zwei oder mehr einheitlichen segmenten

Info

Publication number
ATE542523T1
ATE542523T1 AT05753917T AT05753917T ATE542523T1 AT E542523 T1 ATE542523 T1 AT E542523T1 AT 05753917 T AT05753917 T AT 05753917T AT 05753917 T AT05753917 T AT 05753917T AT E542523 T1 ATE542523 T1 AT E542523T1
Authority
AT
Austria
Prior art keywords
pharmaceutical tablets
uniform segments
tablets
segments
uniform
Prior art date
Application number
AT05753917T
Other languages
English (en)
Inventor
Lawrence Solomon
Allan Kaplan
Original Assignee
Accu Break Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Accu Break Technologies Inc filed Critical Accu Break Technologies Inc
Application granted granted Critical
Publication of ATE542523T1 publication Critical patent/ATE542523T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Glanulating (AREA)
AT05753917T 2004-05-21 2005-05-23 Pharmazeutische tabletten mit zwei oder mehr einheitlichen segmenten ATE542523T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57304204P 2004-05-21 2004-05-21
US57313404P 2004-05-21 2004-05-21
PCT/US2005/018631 WO2005112900A1 (en) 2004-05-21 2005-05-23 Pharmaceutical tablets comprising two or more unitary segments

Publications (1)

Publication Number Publication Date
ATE542523T1 true ATE542523T1 (de) 2012-02-15

Family

ID=35456178

Family Applications (2)

Application Number Title Priority Date Filing Date
AT05754171T ATE552827T1 (de) 2004-05-21 2005-05-23 Pharmazeutische tabletten mit einem relativ inaktiven segment
AT05753917T ATE542523T1 (de) 2004-05-21 2005-05-23 Pharmazeutische tabletten mit zwei oder mehr einheitlichen segmenten

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT05754171T ATE552827T1 (de) 2004-05-21 2005-05-23 Pharmazeutische tabletten mit einem relativ inaktiven segment

Country Status (9)

Country Link
US (6) US8158148B2 (de)
EP (5) EP1755564B1 (de)
JP (5) JP2008500401A (de)
AT (2) ATE552827T1 (de)
AU (5) AU2005245025B2 (de)
CA (5) CA2564961C (de)
ES (4) ES2439572T3 (de)
IL (5) IL179433A0 (de)
WO (5) WO2005112897A2 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
ES2439572T3 (es) * 2004-05-21 2014-01-23 Accu-Break Technologies, Inc. Comprimidos farmacéuticos de liberación inmediata de mayor altura que anchura
US20120201883A1 (en) * 2004-05-21 2012-08-09 Accu-Break Technologies, Inc Antiviral compositons
US20080152595A1 (en) * 2004-11-24 2008-06-26 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of orally administered pharmaceutical products
JP5046501B2 (ja) * 2005-08-18 2012-10-10 帝人ファーマ株式会社 複数の薬物を分離して保持する錠剤
CA2619745A1 (en) * 2005-08-18 2007-02-22 Teijin Pharma Limited Tablet with multiple drug-containing sections
JP5123471B2 (ja) * 2005-08-18 2013-01-23 帝人ファーマ株式会社 用量調整が容易な製剤
KR20080034517A (ko) * 2005-08-18 2008-04-21 데이진 화-마 가부시키가이샤 정확한 용량 분할 기능을 갖는 제제
US8158146B2 (en) 2005-09-28 2012-04-17 Teva Pharmaceutical Industries Ltd. Stable combinations of amlodipine besylate and benazepril hydrochloride
UA92920C2 (ru) * 2005-10-31 2010-12-27 Кова Ко., Лтд. Таблетка с насечкой, включающая питавастатин, и имеющая превосходную фотостабильность
KR101404561B1 (ko) * 2005-12-09 2014-06-11 벡투스 바이오시스템즈 피티와이 리미티드 Ｖｉｐ 단편 및 사용 방법
AU2005339699A1 (en) * 2005-12-30 2007-07-12 Accu-Break Technologies, Inc. Adhesively bonded dosage form
WO2007098446A2 (en) * 2006-02-21 2007-08-30 Accu-Break Pharmaceuticals, Inc. Method for minimizing variation in dosage forms
US20070237815A1 (en) * 2006-04-06 2007-10-11 Lawrence Solomon Dosage forms and methods comprising amlodipine and chlorthalidone
US20080075772A1 (en) * 2006-04-13 2008-03-27 Lawrence Solomon Pharmaceutical compositions having novel scoring patterns and methods of using those compositions
WO2007149860A1 (en) * 2006-06-19 2007-12-27 Accu-Break Technologies, Inc. Segmented pharmaceutical dosage forms
PE20120542A1 (es) 2006-06-27 2012-05-14 Novartis Ag Formas de dosificacion solidas de valsartan, amlodipina e hidroclorotiazida y metodo para elaborarlas
EP2049089A4 (de) * 2006-08-08 2012-07-04 Accu Break Technologies Inc Pharmazeutische tabletten mit mehreren wirkstoffsegmenten
WO2008053297A2 (en) * 2006-10-30 2008-05-08 Wockhardt Research Centre Pharmaceutical compositions comprising entacapone, levodopa, and carbidopa
CA2671092A1 (en) * 2006-11-30 2008-06-05 Accu-Break Technologies, Inc. Divisible osmotic dosage forms and methods of use
USD631537S1 (en) 2009-09-15 2011-01-25 Mcneil-Ppc, Inc. Oral dosage form
US8901113B2 (en) 2009-09-30 2014-12-02 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
US20110280936A1 (en) * 2010-05-17 2011-11-17 Aptapharma, Inc. Self Breaking Tablets
JP5986984B2 (ja) * 2011-03-03 2016-09-06 武田薬品工業株式会社 積層錠剤、その製造方法、および、層剥離抑制方法
ES2691982T3 (es) 2012-11-30 2018-11-29 Acura Pharmaceuticals, Inc. Liberación autorregulada de un principio activo farmacéutico
WO2015145461A1 (en) 2014-03-26 2015-10-01 Sun Pharma Advanced Research Company Ltd. Abuse deterrent immediate release biphasic matrix solid dosage form
US9839212B2 (en) 2015-04-16 2017-12-12 Bio-Lab, Inc. Multicomponent and multilayer compacted tablets
WO2017040607A1 (en) 2015-08-31 2017-03-09 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
JP6745670B2 (ja) * 2016-07-29 2020-08-26 芝浦メカトロニクス株式会社 錠剤印刷装置、錠剤及び錠剤製造方法
US20190060243A1 (en) * 2017-08-25 2019-02-28 MD Medical Research Article and method for a pharmaceutical agent
BR112020017422A2 (pt) * 2018-03-29 2020-12-22 Avion Pharmaceuticals , Llc Composição de dose fracionada de levodopa e uso
CN111407734A (zh) * 2019-01-05 2020-07-14 厦门赛诺邦格生物科技股份有限公司 一种阳痿早泄治疗药物的固体制剂
CN112917981A (zh) * 2020-12-28 2021-06-08 陕西兴盛新材料股份有限公司 一种采用力的转向增压的电极压制工艺

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128226A (en) 1962-08-22 1964-04-07 Hoffmann La Roche Composition for relieving pain
US3336200A (en) 1963-05-28 1967-08-15 Warner Lambert Pharmaceutical Tablet structure
USD201497S (en) 1964-09-28 1965-06-29 Warner Lambert Co Tablet
US3450252A (en) * 1968-04-17 1969-06-17 Richardson Merrell Inc Dispensing container
US3696091A (en) * 1970-06-03 1972-10-03 Boehringer Sohn Ingelheim Novel cardiac-active principles of the cardenolide glycoside class
US3723614A (en) * 1971-01-06 1973-03-27 Ciba Geigy Ag Maltese-cross scored tablet
US3927194A (en) * 1972-12-06 1975-12-16 Ives Lab Inc Tablet formulation
US4215104A (en) * 1979-03-26 1980-07-29 Mead Johnson & Company Multi-fractionable tablet structure
US4258027A (en) * 1979-03-26 1981-03-24 Mead Johnson & Company Multi-fractionable tablet structure
CH648754A5 (en) * 1979-08-16 1985-04-15 Ciba Geigy Ag Pharmaceutical slow release tablet
US4353887A (en) * 1979-08-16 1982-10-12 Ciba-Geigy Corporation Divisible tablet having controlled and delayed release of the active substance
US4473192A (en) * 1982-01-22 1984-09-25 Hoefchst-Roussel Pharmaceuticals Incorporated Tablet breaking device
DE3221425A1 (de) * 1982-06-07 1983-12-08 Boehringer Ingelheim KG, 6507 Ingelheim Hydrolyseempfindlichen wirkstoff enthaltende, lagerstabile tablette
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
JPH069375B2 (ja) 1984-04-27 1994-02-02 株式会社東芝 中間調画情報の符号化伝送方式
US4824677A (en) * 1986-12-18 1989-04-25 The Unjohn Company Grooved tablet for fractional dosing of sustained release medication
US4905589A (en) * 1987-02-06 1990-03-06 Ackley E Michael Ink-jet system for marking pellet-shaped articles
KR900700071A (ko) * 1987-12-17 1990-08-11 로버어트 에이 아미테이지 트리-스코어(Tri-scored) 약 정제
US4999226A (en) * 1988-06-01 1991-03-12 Merrell Dow Pharmaceuticals Inc. Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination
US5041430A (en) * 1989-09-18 1991-08-20 Du Pont Mereck Pharmaceutical Company Oral anticoagulant/platelet inhibitor low dose formulation
US5089270A (en) * 1990-05-15 1992-02-18 L. Perrigo Company Capsule-shaped tablet
US5061494A (en) * 1990-06-14 1991-10-29 The Upjohn Comany Tri-scored drug tablet
GB9107378D0 (en) 1991-04-08 1991-05-22 Ici Plc Olefin polymerisation
US5158728A (en) 1991-04-12 1992-10-27 Elizabeth-Hata International, Inc. Multi-layer medicinal tablet forming machine and method for using the same
US5118021A (en) * 1991-05-10 1992-06-02 American Medical Industries Pill splitter
JPH069375A (ja) * 1992-04-10 1994-01-18 Takeda Chem Ind Ltd 分割可能な連結錠剤
IT1255522B (it) 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
CA2110313C (en) * 1992-12-01 2004-10-26 Edward John Roche Pharmaceutical compositions containing a guanidinothiazole compound and antacids
US6183778B1 (en) * 1993-09-21 2001-02-06 Jagotec Ag Pharmaceutical tablet capable of liberating one or more drugs at different release rates
JP3168582B2 (ja) * 1993-12-10 2001-05-21 藤沢薬品工業株式会社 解熱鎮痛配合剤
GB9401894D0 (en) 1994-02-01 1994-03-30 Rhone Poulenc Rorer Ltd New compositions of matter
TW483763B (en) * 1994-09-02 2002-04-21 Astra Ab Pharmaceutical composition comprising of ramipril and dihydropyridine compound
US5756124A (en) 1995-08-07 1998-05-26 Invamed, Inc. Multi-scored pharmaceutical tablets
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
GB9624563D0 (en) 1996-11-27 1997-01-15 Smithkline Beecham Plc Product
NZ508567A (en) * 1998-06-03 2004-02-27 Alza Corp Methods and devices for providing prolonged drug therapy
US6602521B1 (en) 1998-09-29 2003-08-05 Impax Pharmaceuticals, Inc. Multiplex drug delivery system suitable for oral administration
US8293277B2 (en) * 1998-10-01 2012-10-23 Alkermes Pharma Ireland Limited Controlled-release nanoparticulate compositions
DE19927688A1 (de) * 1999-06-17 2000-12-21 Gruenenthal Gmbh Mehrschichttablette zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac
US6375956B1 (en) * 1999-07-22 2002-04-23 Drugtech Corporation Strip pack
JP2001187749A (ja) * 1999-10-18 2001-07-10 Tanabe Seiyaku Co Ltd 長期徐放性圧縮成型製剤およびその製造法
US7674480B2 (en) * 2000-06-23 2010-03-09 Teva Pharmaceutical Industries Ltd. Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
EP1330236A2 (de) 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Amoxicillinhaltige arzneizusammensetzungen
US6555581B1 (en) * 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
CN1606434A (zh) * 2001-12-19 2005-04-13 株式会社三和化学研究所 控制释放成型品
JP4724367B2 (ja) * 2002-01-15 2011-07-13 ユセベ ファルシム ソシエテ アノニム 処方
US6946156B2 (en) * 2002-05-15 2005-09-20 Mcneil-Ppc, Inc. Process for enrobing a core
CA2512666A1 (en) * 2003-01-08 2004-07-29 Flacco-Nesselroad Family Trust Combination therapy for anticoagulation
KR20060016787A (ko) * 2003-06-06 2006-02-22 다케다 야쿠힌 고교 가부시키가이샤 고형 약학 제제
US20050013863A1 (en) 2003-07-18 2005-01-20 Depomed, Inc., A Corporation Of The State Of California Dual drug dosage forms with improved separation of drugs
TWI366110B (en) * 2004-02-26 2012-06-11 Ibm Providing a portion of an electronic mail message based upon a transfer rate, a message size, and a file format
US7622137B2 (en) * 2004-05-21 2009-11-24 Accu-Break Technologies, Inc. Dosage forms contained within a capsule or sachet
US7713547B2 (en) * 2004-05-21 2010-05-11 Accu-Break Pharmaceuticals, Inc. Method of administering a partial dose of a segmented pharmaceutical tablet
ES2439572T3 (es) * 2004-05-21 2014-01-23 Accu-Break Technologies, Inc. Comprimidos farmacéuticos de liberación inmediata de mayor altura que anchura
US7318935B2 (en) * 2004-05-21 2008-01-15 Accu-Break Technologies, Inc. Pharmaceutical tablets with active and inactive segments
US7838031B2 (en) * 2004-05-21 2010-11-23 Lawrence Solomon Method of administering a partial dose using a segmented pharmaceutical tablet
US7329418B2 (en) * 2004-05-21 2008-02-12 Accu Break Technologies, Inc. Pharmaceutical tablets having height greater than width

Also Published As

Publication number Publication date
WO2005112870A1 (en) 2005-12-01
US20080199521A1 (en) 2008-08-21
AU2005245028A1 (en) 2005-12-01
US20080003285A1 (en) 2008-01-03
EP1750647A1 (de) 2007-02-14
EP1755564A4 (de) 2007-07-04
ES2429540T3 (es) 2013-11-15
EP1750647A4 (de) 2007-07-04
EP1755564B1 (de) 2013-10-16
EP1746979A4 (de) 2007-07-04
AU2005245027B2 (en) 2011-05-19
AU2005292670A1 (en) 2006-04-13
JP2008500403A (ja) 2008-01-10
IL179429A0 (en) 2007-05-15
WO2005112900A1 (en) 2005-12-01
US8034380B2 (en) 2011-10-11
EP1755563B1 (de) 2012-01-25
US20080233189A1 (en) 2008-09-25
WO2005112898A1 (en) 2005-12-01
CA2564961C (en) 2014-07-15
AU2005245028B2 (en) 2010-12-09
CA2564962C (en) 2013-08-06
CA2566310C (en) 2014-05-13
EP1755560A4 (de) 2007-07-04
WO2005112897A2 (en) 2005-12-01
AU2005245026B2 (en) 2010-07-01
JP5395355B2 (ja) 2014-01-22
CA2565029C (en) 2013-09-03
US20070134321A1 (en) 2007-06-14
EP1750647B1 (de) 2014-11-19
CA2564961A1 (en) 2005-12-01
US8158148B2 (en) 2012-04-17
ES2379967T3 (es) 2012-05-07
WO2005112897A3 (en) 2006-09-21
ES2385832T3 (es) 2012-08-01
ES2439572T3 (es) 2014-01-23
EP1755560A1 (de) 2007-02-28
ATE552827T1 (de) 2012-04-15
CA2565029A1 (en) 2005-12-01
EP1746979A2 (de) 2007-01-31
JP2008500402A (ja) 2008-01-10
AU2005245027A1 (en) 2005-12-01
CA2564960A1 (en) 2005-12-01
EP1755563A1 (de) 2007-02-28
AU2005245025B2 (en) 2010-06-03
WO2006038916A3 (en) 2006-10-12
CA2566310A1 (en) 2006-01-13
US20090130207A1 (en) 2009-05-21
EP1755564A2 (de) 2007-02-28
AU2005245026A1 (en) 2005-12-01
US7988996B2 (en) 2011-08-02
JP2008500400A (ja) 2008-01-10
IL179430A0 (en) 2007-05-15
IL179433A0 (en) 2007-05-15
US20080241239A1 (en) 2008-10-02
WO2006038916A2 (en) 2006-04-13
JP2008500401A (ja) 2008-01-10
IL179432A0 (en) 2007-05-15
IL179431A0 (en) 2007-05-15
EP1746979B1 (de) 2013-09-11
CA2564962A1 (en) 2005-12-01
US7879352B2 (en) 2011-02-01
JP2008500404A (ja) 2008-01-10
AU2005292670B2 (en) 2011-02-03
JP5008565B2 (ja) 2012-08-22
AU2005245025A1 (en) 2005-12-01
EP1755560B1 (de) 2012-04-11
EP1755563A4 (de) 2007-07-04

Similar Documents

Publication Publication Date Title
ATE542523T1 (de) Pharmazeutische tabletten mit zwei oder mehr einheitlichen segmenten
CY1120377T1 (el) Στερεη φαρμακευτικη δοσολογικη φαρμακοτεχνικη μορφη που περιεχει λοπιναβιρη
UY28281A1 (es) Productos farmacéuticos
DE60210828D1 (de) Pharmazeutische pellets enthaltend tamsulosin sowie deren herstellungsverfahren
CR20120661A (es) Dosificación en forma sólida para farmacéuticos
ITMI20031310A1 (it) Geogriglia o struttura a maglie e metodo per la sua fabbricazione.
RS52057B (en) Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof
AR046994A1 (es) Proceso para la produccion de una forma de dosificacion a prueba de abuso
EP1849470A4 (de) Arzneistoff gegen krebs mit alpha, alpha, alpha-trifluorthymidin und thymidin-phosphorylase-inhibitor
NO20053586L (no) Platemateriale for et radiobolgeabsorberende legeme, og radiobolgeabsorberende legeme.
ZA200701059B (en) Pharmaceutical dosage forms comprising a low-solubllity drug and a polymer
AR033467A1 (es) Comprimido de meloxicam de rapida disgregacion
EP1961413A4 (de) Schnell zerfallende orale tablette
ZA200506992B (en) Fibrate tablet and method for the production thereof
DE60111503D1 (de) Pharmazeutische zusammensetzungen enthaltend terbinafin
DK1750765T3 (da) Farmaceutisk antimykobakteriesammensætning omfattende et antituberkulöst lægemiddel
PA8644401A1 (es) Composicion farmaceutica
GT200500251A (es) Composicion farmaceutica
ATE479428T1 (de) Olanzapin enthaltende pharmazeutische zusammensetzung
PT2117533E (pt) Composição farmacêutica à base de stachytarpheta sp., processo para a sua obtenção e sua utilização no tratamento de vitiligo
CO2025013863A2 (es) Composición oral sólida de olaparib y sus sales
FR2859632B1 (fr) Comprime multisecable a observance amelioree.
UA81732C2 (ru) Фармацевтическая композиция, содержащая zd6474
UA3057U (uk) Спосіб профілактики сальпінгоофоритів у дівчат-підлітків після апендектомії
RU2004115195A (ru) Способ повышения антигельминтного действия фенбендазола